Spyre Therapeutics Inc (SYRE)

Total Costs & Expenses

$291.83M

TTM · Period ending: · USD

SYRE logo

SYRE Total Costs & Expenses

Latest reported$291.83M
SYRE TTM Total Costs & Expenses ($8.90M → $291.83M)
High-resolution chart · PNG

SYRE total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Spyre Therapeutics Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
291,834,000
292,130,000
300,056,000
213,643,000
212,147,000
214,359,000
208,566,000
193,227,000
156,172,000
271,959,000
243,189,000
216,605,000
217,197,000
80,311,000
87,110,000
91,866,000
94,629,000
91,982,000
84,388,000
83,078,000
79,509,000
80,668,000
81,481,000
80,614,000
84,637,000
81,699,000
80,334,000
73,730,000
63,827,000
57,253,000
49,351,000
42,154,000
39,170,000
35,321,000
32,879,000
31,561,000
29,752,000
28,421,000
26,534,000
25,326,000
22,366,000
20,357,000
17,400,000
14,999,000
13,649,000
10,516,000
8,904,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.